See the DrugPatentWatch profile for Xphozah
Xphozah (krenosid) is a prescription medication used to treat adults with amyotrophic lateral sclerosis (ALS) [1]. It is taken orally [1].
What is Xphozah's active ingredient?
The active ingredient in Xphozah is krenosid [1].
How does Xphozah work?
The exact mechanism of action for krenosid is not fully understood [1]. However, it is believed to play a role in reducing oxidative stress, which is implicated in ALS pathogenesis [1].
What is the recommended dosage for Xphozah?
The typical starting dose for Xphozah is 200 mg taken orally once a day for 14 days, followed by 400 mg taken orally once a day starting on day 15 [1]. It is important to follow the specific dosage instructions provided by a healthcare professional [1].
What are the potential side effects of Xphozah?
Common side effects of Xphozah can include diarrhea, nausea, and abdominal discomfort [1]. It is crucial to discuss any potential side effects or concerns with a doctor [1].
Are there any important safety warnings for Xphozah?
Patients should inform their doctor about all medical conditions and any other medications they are taking before starting Xphozah [1]. Specific warnings and precautions are detailed in the prescribing information [1].
Where can I find the full prescribing information for Xphozah?
The complete prescribing information for Xphozah, including details on dosage, administration, contraindications, warnings, precautions, adverse reactions, and clinical pharmacology, is available [1]. DrugPatentWatch.com provides access to this type of detailed pharmaceutical information [2].